Retamol

Retamol is a branded generic formulation of paracetamol (acetaminophen) developed and marketed by SNIG Pharma. It is a small molecule non-opioid analgesic and antipyretic used for the management of mild to moderate pain and the reduction of fever. Retamol is particularly indicated for short-term treatment in clinical settings, such as post-operative care, where rapid relief is required or oral administration is not feasible. The drug's mechanism of action involves the inhibition of prostaglandin synthesis within the central nervous system and a direct effect on the hypothalamic heat-regulating center to produce antipyresis. It is commonly available as a 1000 mg intravenous infusion, providing a high-dose, fast-acting alternative to oral paracetamol formulations.

Brand names

Retamol

Other names

paracetamolacetaminophenN-acetyl-p-aminophenolAPAP